Conditions for the Utilization of Human Pluripotent Stem Cells Derived From Fetal Tissue.
"a. Unlike pluripotent stem cells derived from human embryos,
DHHS funds may be used to support research to derive pluripotent stem
cells from fetal tissue, as well as for research utilizing such cells.
Such research is governed by Federal statutory restrictions regarding
fetal tissue research . . . In addition, because cells derived from
fetal tissue at the early stages of investigation may, at a later date,
be used in human fetal tissue transplantation research, it is the policy
of NIH to require that all NIH-funded research involving the derivation
or utilization of pluripotent stem cells from human fetal tissue also
comply with the fetal tissue transplantation statute."